AstraZeneca reports positive results from blood cancer drug

AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Related Keywords

Houston , Texas , United States , Michael Wang , Susan Galbraith , Astrazeneca , Md Anderson Cancer Center , Cancer Center , Reports , Positive , Results , From , Blood , Cancer , Drug , Trial , Category All , Category Company News , Category News And Announcements , Category Sectorial Health Technology , Mostread All , Mostread Company News ,